Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Labaki

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer Cell|April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
Science Advances|February 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and <i>BAP1</i> lossSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research SummitToni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Nature Cancer|January 9, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinomaTejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2021
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes studySheena Bhalla, Ziad Bakouny, Andrew L Schmidt, et al.
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Cell|April 5, 2024
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesRenée Maria Saliby, Chris Labaki, Tejas R Jammihal, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
Science Advances|February 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and <i>BAP1</i> lossSabrina Y Camp, Meng Xiao He, Michael S Cuoco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
From Basic Science to Clinical Translation in Kidney Cancer: A Report from the Second Kidney Cancer Research SummitToni K Choueiri, Laurence Albiges, Michael B Atkins, et al.
Nature Cancer|January 9, 2025
Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinomaTejas Jammihal, Renee Maria Saliby, Chris Labaki, et al.
Cancer Cell|September 30, 2022
Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitorsAmin H Nassar, Elio Adib, Sarah Abou Alaiwi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 30, 2021
Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes studySheena Bhalla, Ziad Bakouny, Andrew L Schmidt, et al.
Nature Medicine|December 16, 2022
Germline variants associated with toxicity to immune checkpoint blockadeStefan Groha, Sarah Abou Alaiwi, Wenxin Xu, et al.
Lancet Regional Health. Americas|March 24, 2025
Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infectionEmily Pei-Ying Lin, Chih-Yuan Hsu, Sanjay Mishra, et al.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
Pageof 8